Latest News for SIFY
Sify Technologies Limited remains rated Hold as long-term growth potential is offset by persistent financial and execution risks. SIFY's aggressive data center expansion boosts capacity but strains free cash flow and profitability, with capital spending at 26% of sales and negative free cash flow. Despite 15% YoY revenue and 42% EBITDA growth, SIFY's premium valuation (700x forward earnings) is difficult to justify…
Sify Technologies Limited (SIFY) Q1 2027 Earnings Call Transcript
Sify Technologies NASDAQ: SIFY reported higher first-quarter revenue and adjusted EBITDA for fiscal 2026-27, as management pointed to continued demand for data centers, network modernization and digital infrastructure tied to cloud, artificial intelligence and data-intensive workloads.
Revenues of INR 12,352 Million. Adjusted EBITDA of INR 3,005 Million.
Investors interested in stocks from the Internet - Services sector have probably already heard of HealthStream (HSTM) and Sify Technologies Limited (SIFY). But which of these two companies is the best option for those looking for undervalued stocks?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SIFY.
U.S. House Trading
No House trades found for SIFY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.